Maria Carmen Arroyo Sanchez

Maria Carmen Arroyo Sanchez

Auto-generated profile, based on publicly available information

Maria Carmen Arroyo Sanchez

Programa de Pós Graduação em Doenças Infecciosas e Saúde Global, Departamento de Infectologia e Medicina Tropical, Faculdade de Medicina Universidade de São Paulo São Paulo Brazil

Research Focus & Metrics

Academic Career Length

42Years (1985-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2006 in Journal of Clinical Laboratory Analysis
Verified
Journal Article
Open access
PDF file
GEGuita Rubinsky Elefant
Guita Rubinsky Elefant
SSSumie Hoshino Shimizu
Sumie Hoshino Shimizu
MSMaria Carmen Arroyo Sanchez
Maria Carmen Arroyo Sanchez
CJCristina Miuki Abe Jacob
Cristina Miuki Abe Jacob
AFAntonio Walter Ferreira
Antonio Walter Ferreira
A serological follow‐up study was carried out on 27 children (1–12 years old) with visceral and/or ocular toxocariasis, after treatment with thiabendazole. A total of 159 serum samples were collected in a period ranging from 22–116 months. Enzyme‐linked immunosorbent assays (IgG, IgA, and IgE ELISA) were standardized, using excretory–secretory antigens obtained from the second‐stage larvae of aToxocara canisculture. The sensitivity found for the IgG, IgA, and IgE ELISA, as determined in visceral toxocariasis patients, was 100%, 47.8%, and 78.3%, respectively. Approximately 84% of the patients presented single or multiple parasitosis, as diagnosed by stool examination, yet such variables did not appear to affect the anti‐Toxocaraimmune response. Titers of specific IgE antibody showed a significant decrease during the first year after treatment, followed by a decrease in the IgA titers in the second year, and in the IgG titers from the fourth year onwards. Sera from all patients presented high avidity IgG antibodies, indicating that they were in the chronic phase of the disease. Moreover, 1 year after treatment, the level of leukocytes, eosinophils, and anti‐A isohemagglutinin in patients decreased significantly. The present data suggest that IgE antibodies plus eosinophil counts are helpful parameters for patient follow‐up after chemotherapy. J. Clin. Lab. Anal. 20:164–172, 2006.

24 September 2008 in Malaria Journal
Verified
Journal Article
Open access
PDF file
FLFabiana Ms Leoratti
Fabiana Ms Leoratti
RDRui R Durlacher
Rui R Durlacher
MLMarcus Vg Lacerda
Marcus Vg Lacerda
MAMaria G Alecrim
Maria G Alecrim
AFAntonio W Ferreira
Antonio W Ferreira
SMSandra L Moraes
Sandra L Moraes
Background: The development of protective immunity against malaria is slow and to be maintained, it requires exposure to multiple antigenic variants of malaria parasites and age-associated maturation of the immune system. Evidence that the protective immunity is associated with different classes and subclasses of antibodies reveals the importance of considering the quality of the response. In this study, we have evaluated the humoral immune response againstPlasmodium falciparumblood stages of individuals naturally exposed to malaria who live in endemic areas of Brazil in order to assess the prevalence of different specific isotypes and their association with different malaria clinical expressions.Methods: Different isotypes againstP. falciparumblood stages, IgG, IgG1, IgG2, IgG3, IgG4, IgM, IgE and IgA, were determined by ELISA. The results were based on the analysis of different clinical expressions of malaria (complicated, uncomplicated and asymptomatic) and factors related to prior malaria exposure such as age and the number of previous clinical malaria attacks. The occurrence of the H131 polymorphism of the FcγIIA receptor was also investigated in part of the studied population.Results: The highest levels of IgG, IgG1, IgG2 and IgG3 antibodies were observed in individuals with asymptomatic and uncomplicated malaria, while highest levels of IgG4, IgE and IgM antibodies were predominant among individuals with complicated malaria. Individuals reporting more than five previous clinical malaria attacks presented a predominance of IgG1, IgG2 and IgG3 antibodies, while IgM, IgA and IgE antibodies predominated among individuals reporting five or less previous clinical malaria attacks. Among individuals with uncomplicated and asymptomatic malaria, there was a predominance of high-avidity IgG, IgG1, IgG2 antibodies and low-avidity IgG3 antibodies. The H131 polymorphism was found in 44.4% of the individuals, and the highest IgG2 levels were observed among asymptomatic individuals with this allele, suggesting the protective role of IgG2 in this population.Conclusion: Together, the results suggest a differential regulation in the anti-P. falciparumantibody pattern in different clinical expressions of malaria and showed that even in unstable transmission areas, protective immunity against malaria can be observed, when the appropriated antibodies are produced.

25 September 2006 in Tropical Medicine & International Health
Verified
Journal Article
Closed access
PDF file
CFClaudia De Abreu Fonseca
Claudia De Abreu Fonseca
VFVera Lúcia Teixeira de Freitas
Vera Lúcia Teixeira de Freitas
EREliete Caló Romero
Eliete Caló Romero
CSClaudia Spinosa
Claudia Spinosa
MSMaria Carmem Arroyo Sanches
Maria Carmem Arroyo Sanches
MSMaria Aparecida Shikanai-Yasuda
Maria Aparecida Shikanai-Yasuda

1 September 2011 in Memórias do Instituto Oswaldo Cruz
Verified
Journal Article
Open access
PDF file
GLGiselle Fmc Lima
Giselle Fmc Lima
JLJosé E Levi
José E Levi
MGMarcelo P Geraldi
Marcelo P Geraldi
MSMaria Carmen A Sanchez
Maria Carmen A Sanchez
ASAluísio Ac Segurado
Aluísio Ac Segurado
SSSilvia Maria Di Santi
Silvia Maria Di Santi
Malaria diagnoses has traditionally been made using thick blood smears, but more sensitive and faster techniques are required to process large numbers of samples in clinical and epidemiological studies and in blood donor screening. Here, we evaluated molecular and serological tools to build a screening platform for pooled samples aimed at reducing both the time and the cost of these diagnoses. Positive and negative samples were analysed in individual and pooled experiments using real-time polymerase chain reaction (PCR), nested PCR and an immunochromatographic test. For the individual tests, 46/49 samples were positive by real-time PCR, 46/49 were positive by nested PCR and 32/46 were positive by immunochromatographic test. For the assays performed using pooled samples, 13/15 samples were positive by real-time PCR and nested PCR and 11/15 were positive by immunochromatographic test. These molecular methods demonstrated sensitivity and specificity for both the individual and pooled samples. Due to the advantages of the real-time PCR, such as the fast processing and the closed system, this method should be indicated as the first choice for use in large-scale diagnosis and the nested PCR should be used for species differentiation. However, additional field isolates should be tested to confirm the results achieved using cultured parasites and the serological test should only be adopted as a complementary method for malaria diagnosis.

1 February 2011 in Revista do Instituto de Medicina Tropical de São Paulo
Verified
Journal Article
Open access
PDF file
PSPatricia Scuracchio
Patricia Scuracchio
SVSergio Domingos Vieira
Sergio Domingos Vieira
DDDenise Albuquerque Dourado
Denise Albuquerque Dourado
LBLuciana Moro Bueno
Luciana Moro Bueno
RCRafael Colella
Rafael Colella
SSSilvia Maria Di Santi
Silvia Maria Di Santi
Malaria in Brazil is endemic in the Amazon region, but autochthonous cases with low parasitaemia occur in the Atlantic Forest area of the country. According to Brazilian legislation no test is mandatory for blood donors from non-endemic areas. However if they have traveled to malaria transmission regions they are deferred for six months before they can donate. This report describes a transfusion-transmitted malaria case in Sao Paulo, Brazil, where one recipient received infected blood and developed the disease. He lived in Sao Paulo and had no previous transfusion or trips to endemic areas, including those of low endemicity, such as Atlantic Forest. Thick blood smears confirmed Plasmodium malariae. All donors lived in Sao Paulo and one of them (Donor 045-0) showed positive hemoscopy and PCR. This asymptomatic donor had traveled to Juquia, in the Atlantic Forest area of S ao Paulo State, where sporadic cases of autochthonous malaria are described. DNA assay revealed P. malariae in the donor's (Donor 045-0) blood. Serum archives of the recipient and of all blood donors were analyzed by ELISA using both P. vivax and P. falciparum antigens, and IFAT with P. malariae. Donor 045-0's serum was P. malariae IFAT positive and the P. vivax ELISA was reactive. In addition, two out of 44 donors' archive sera were also P. vivax ELISA reactive. All sera were P. falciparum ELISA negative. This case suggests the need of reviewing donor selection criteria and deferral strategies to prevent possible cases of transfusion-transmitted malaria.

24 November 2008 in Tropical Medicine & International Health
Verified
Journal Article
Open access
PDF file
CFCelia Regina Furuchó
Celia Regina Furuchó
EUEufrozina S. Umezawa
Eufrozina S. Umezawa
IAIgor Almeida
Igor Almeida
VFVera L. Freitas
Vera L. Freitas
RBRita Bezerra
Rita Bezerra
MSMaria Aparecida Shikanai-Yasuda
Maria Aparecida Shikanai-Yasuda
Summary: Objective  To find the most reliable screening method for Trypanosoma cruzi infection in blood banks.Material and methods  Epidemiological data, lymphoproliferation assay, parasitological, conventional serological tests: immunofluorescence, haemagglutination, ELISA with epimastigote and trypomastigote antigens and reference serological tests: trypomastigote excreted‐secreted antigens (TESA) blot and chemiluminescent ELISA assay with mucine from trypomastigote forms were applied to individuals with inconclusive serology, non‐chagasic individuals and chronic chagasic patients.Results  TESA blot had the best performance when used as a single test in all the groups. In the inconclusive group 20.5% of individuals were positive for TESA blot, 23.3% for either lymphoproliferation or TESA blot, and 17.8% for lymphoproliferation only. Positive lymphoproliferation without detectable antibodies was observed in 5.47% of all inconclusive serology cases. Analysis of six parameters (three serological assays, at least one parasitological test, one lymphoproliferation assay and epidemiological data) in the inconclusive group showed that diagnosis of Chagas’ disease was probable in 15 patients who were positive by two or more serological tests or for whom three of those six parameters were positive.Conclusion  TESA blot is a good confirmatory test for Chagas’ disease in the inconclusive group. Although lymphoproliferation suggests the diagnosis of Chagas’ disease in the absence of antibodies when associated with a high epidemiological risk of acquiring Chagas’ disease, the data from this study and the characteristics of the lymphoproliferation assay (which is both laborious and time‐consuming) do not support its use as a confirmatory test in blood‐bank screening. However, our findings underscore the need to develop alternative methods that are not based on antibody detection to improve the diagnosis when serological tests are inconclusive.